Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2005;106:340-344
© 2005 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Anna, R.
Right arrow Articles by Jasonni, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Anna, R.
Right arrow Articles by Jasonni, V. M.
Related Collections
Right arrow Basic Science
Right arrow Hypertension and PIH

ORIGINAL RESEARCH

Plasma Adiponectin Concentration in Early Pregnancy and Subsequent Risk of Hypertensive Disorders

Rosario D'Anna, MD, Giovanni Baviera, PhD, Francesco Corrado, MD, Domenico Giordano, MD, Antonino Di Benedetto, MD and Valerio M. Jasonni, MD

From the Department of Obstetrics and Gynecology and Department of Internal Medicine, University of Messina, Messina Italy; and the Department of Obstetrics and Gynecology, University of Modena, Modena, Italy.

Objective: Adiponectin is an exclusively adipose tissue–derived protein. Low plasma adiponectin levels have been found in hypertensive men. Our objective was to evaluate whether low first-trimester plasma adiponectin values were predictive of hypertensive disorders later in pregnancy.

Methods: A nested case-control study was carried out on a cohort of 1,842 pregnant women who participated in the first-trimester Down syndrome screening program; 34 developed preeclampsia and 48 gestational hypertension. A control group of 82 nonhypertensive uneventful pregnancies was selected. Plasma adiponectin was determined using an enzyme-linked immunosorbent assay (ELISA).

Results: Adiponectin median concentrations in the group which subsequently became hypertensive were significantly lower than those in the control group (7.6 versus 13.0 µg/mL) (P < .001). When the 2 hypertensive subgroups were considered, the plasma adiponectin median value in the preeclampsia group was significantly lower than that in the gestational hypertension group (6.6 versus 9.3 µg/mL) (P = .01). Regression analysis showed an inverse correlation between plasma adiponectin concentrations and maternal age, gestational age, body mass index, systolic blood pressure, and proteinuria. Approximately 34% of hypertensive pregnancies, compared with 7% of controls (P < .001), had plasma adiponectin concentrations less than 6.4 µg/mL (mean value of lower quartile of distribution among control patients). After adjusting for maternal age, all these women experienced a 6.6-fold (95% confidence interval 2.5–17.8) increased risk of pregnancy hypertension, compared with those women who had higher concentrations

Conclusion: Our findings suggest a strong association between hypoadiponectinemia and the risk of hypertensive disorders in pregnancy, especially with preeclampsia.

Level of Evidence: II-2




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Fasshauer, T. Waldeyer, J. Seeger, S. Schrey, T. Ebert, J. Kratzsch, U. Lossner, M. Bluher, M. Stumvoll, R. Faber, et al.
Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function
Eur. J. Endocrinol., February 1, 2008; 158(2): 197 - 201.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, N. Potischman, and R. N. Hoover
Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo
Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Lin, F. B. Hu, and G. Curhan
Serum Adiponectin and Renal Dysfunction in Men With Type 2 Diabetes
Diabetes Care, February 1, 2007; 30(2): 239 - 244.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Obstetricians and Gynecologists.